Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failure.

Predictors of cause‐specific hospital readmission in patients with heart failure

“…These results are in agreement with previous reports demonstrating that patients with HF average at least one hospital admission per year, ranging from 0.95 to 2.10 per patient per year. 8,[15][16][17][18][19][20] In the analysis of cause-specific readmission, our rates of readmission for recurrent HF and CVD were comparable with those of other populations with prior reported rates of 7-57%. 16,17,19,20 …”

The effect of a tailored message intervention on heart failure readmission rates, quality of life, and benefit and barrier beliefs in persons with heart failure

“…The 35% of subjects rehospitalized in this study is comparable to rates reported in the literature of 29% to 66% for other samples with HF. 11,54,55 Previous research has demonstrated that persons with HF are frequently readmitted for the same reason as their primary admission because a period of time is required for stabilization of fluid status and adjustment to new medication doses. 8 With shorter lengths of hospital stay, elderly subjects with HF have not had the time to adjust physiologically to altered doses or additional medications.…”

Heart Failure in the Elderly

“…A total of 30-50% of patients with this disorder are readmitted within 6 months of initial hospital discharge [149,150]. Factors contributing to this high readmission rate are the failure to identify and correct treatable causes of HF, underutilization of and nonadherence to therapies, medication side effects and drug interactions and inadequate attention to the psychological and social situation of the patient [149,150].…”

“…A total of 30-50% of patients with this disorder are readmitted within 6 months of initial hospital discharge [149,150]. Factors contributing to this high readmission rate are the failure to identify and correct treatable causes of HF, underutilization of and nonadherence to therapies, medication side effects and drug interactions and inadequate attention to the psychological and social situation of the patient [149,150]. Numerous observational studies and randomized trials have investigated the beneficial effects of multidisciplinary strategies for HF disease management and found a 30-50% reduction in readmission rates with cost savings, improved QOL, enhanced compliance with medication and reduction in mortality [148,151,152].…”